Stable CAD (Coronary artery disease)

Find all the latest content on stable coronary artery disease (stable CAD) published on this website.

A complex and changing disease state requiring wide expertise, stable CAD can involve a diverse range of underlying chronic or evolutionary stages involving full use of all available tools, devices and techniques like those for invasive imaging and functional assessment. Taking into account underlying comorbidities such as diabetes is critical. Advances in imaging techniques, as well as the use of adjunctive pharmacotherapy, vascular access or invasive interventions such as bypass surgery, are important, as are understanding bleeding risks, all of which can be found here…

Filtered By
Stable CAD

348 results

Abstracts - Coronary interventions - Session 1

06 Oct 2022 – From AICT-AsiaPCR 2022

Clinical cases - Coronary interventions - Session 3

06 Oct 2022 – From AICT-AsiaPCR 2022

Clinical cases - Coronary interventions - Session 2

06 Oct 2022 – From AICT-AsiaPCR 2022

Abstracts - Coronary interventions - Session 2

06 Oct 2022 – From AICT-AsiaPCR 2022

BYPASS-CTCA: The value of computed tomography cardiac angiography in improving patient satisfaction and reducing contrast load, procedural duration and complications in patients who had previous CABG undergoing invasive coronary angiography

19 Sep 2022

Nicola Ryan provides her take on the BYPASS-CTCA Study which was presented by Daniel A. Jones at the TCT Congress 2022.

It must be understood that the paper has yet to be published for this study therefore all assumptions are based upon the presented data.

Nicola Ryan

Author

Nicola Ryan
Trial Computed Tomography Cardiac Angiography Contrast Load Procedural Duration CABG Invasive Coronary Angiography

15-month results of the MASTER DAPT trial

01 Sep 2022

Alex Sticchi provides his take on the final results of the MAnagement of high bleeding risk patients post bioresorbable polymer coated STEnt implantion with an abbReviated versus prolonged DAPT regimen

Alessandro Sticchi

Author

Alessandro Sticchi
15-month results of the MASTER DAPT trial

PANTHER - P2Y12 inhibitor versus aspirin monotherapy in patients with coronary artery disease

30 Aug 2022

Elad Asher provides his take on the PANTHER trial which was presented at the ESC Congress 2022 in Barcelona

Elad Asher

Author

Elad Asher
PANTHER - P2Y12 inhibitor versus aspirin monotherapy in patients with coronary artery disease

2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery

29 Aug 2022

The above guideline was published during the 2022 ESC Congress in Barcelona and was chaired by Professor Julinda Mehilli (Germany) and Professor Sigrun Halvorsen (Norway). This guideline was developed by the task force for cardiovascular assessment and management of patients undergoing non-cardiac surgery of the European Society...

Vijay Kunadian

Author

Vijay Kunadian
2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery

ISCHEMIA-CKD EXTEND: revascularization does not improve outcomes at 5 years in patients with advanced chronic kidney disease

29 Aug 2022

Panagiotis Xaplanteris reports on the ISCHEMIA-CKD EXTEND trial results - clinical outcomes at 5 years of follow-up, which were presented during the ESC 2022 congress in Barcelona.

Panagiotis Xaplanteris

Author

Panagiotis Xaplanteris
ISCHEMIA-CKD EXTEND - Clinical Outcomes at 5 years of Follow-up

Association of medication adherence with health outcomes in the ISCHEMIA Trial

26 Aug 2022

This sub-analysis of ISCHEMIA has shown that implementation of a simple protocol of optimal medical therapy is a key factor to improve health outcome and practical in real-world settings.

Dr. Mirvat Alasnag

Reviewer

Mirvat Alasnag
Han Naung Tun

Reviewer

Han Naung Tun
Association of medication adherence with health outcomes in the ISCHEMIA Trial